These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 9333817)

  • 41. Beyond the clinic: redefining hospital ambulatory care.
    Rogut L
    Pap Ser United Hosp Fund N Y; 1997 Jul; ():1-62. PubMed ID: 10351749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Results of the treatment and dispensary observation of patients with chronic destructive pulmonary tuberculosis].
    Repnitskaia ZD
    Probl Tuberk; 1973; 51(5):72-5. PubMed ID: 4757051
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of a unified treatment regimen for all new cases of tuberculosis using guardian-based supervision.
    Banerjee A; Harries AD; Mphasa N; Nyirenda TE; Veen J; Ringdal T; Van Gorkom J; Salaniponi FM
    Int J Tuberc Lung Dis; 2000 Apr; 4(4):333-9. PubMed ID: 10777082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment effectiveness in newly detected patients with destructive pulmonary tuberculosis suffering from alcoholism].
    Molev VP; Golovko AF
    Probl Tuberk; 1986; (8):25-7. PubMed ID: 3774788
    [No Abstract]   [Full Text] [Related]  

  • 45. [Centralized control over the accuracy of the diagnosis of newly detected tuberculosis patients, over the organization and effectiveness of their treatment and over the dispensary observation and treatment of patient contingents in tuberculosis institutions].
    Probl Tuberk; 1985; (4):72-5. PubMed ID: 3873652
    [No Abstract]   [Full Text] [Related]  

  • 46. [Long-term follow-up of newly diagnosed patients with destructive pulmonary tuberculosis].
    Kovaleva SI; Kolosovskaia VP; Voloshina EP
    Probl Tuberk; 1995; (3):9-11. PubMed ID: 7617645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The course of a process and the efficiency of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis with extensive drug resistance to antituberculous drugs].
    Mishin VIu; Komissarova OG; Chukanov VI; Kononets AS
    Probl Tuberk Bolezn Legk; 2009; (2):50-2. PubMed ID: 19382643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Results of treatment in patients with destructive pulmonary tuberculosis without consideration of drug sensitivity in Mycobacterium tuberculosis].
    Abashev IM; Kozlova AI; Ivanova LN
    Probl Tuberk Bolezn Legk; 2008; (1):33-5. PubMed ID: 18318228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DOTS centre at a tertiary care teaching hospital.
    Chokhani R; Pathak V
    Nepal Med Coll J; 2006 Mar; 8(1):19-21. PubMed ID: 16827084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis].
    Lovacheva OV; Erokhin VV; Chernichenko NV; Evgushchenko GV; Lepekha LN; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (10):12-7. PubMed ID: 17139825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Enhancing treatment efficiency of patients with pulmonary tuberculosis by regional lymphotropic therapy].
    Ubaĭdullaev AM; Belotserkovskiĭ VG
    Probl Tuberk; 1999; (6):14-6. PubMed ID: 10715948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ambulatory treatment of pulmonary tuberculosis of primary diagnosis at the antitubercular outpatient clinics in Sardinia].
    Bagiella P; Mura R; Scarpa AL
    G Ital Mal Torace; 1971; 25(1):25-9. PubMed ID: 5131785
    [No Abstract]   [Full Text] [Related]  

  • 53. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of delayed treatment response in pulmonary tuberculosis: use of time to positivity values of Bactec cultures.
    Carroll NM; Uys P; Hesseling A; Lawrence K; Pheiffer C; Salker F; Duncan K; Beyers N; van Helden PD
    Tuberculosis (Edinb); 2008 Nov; 88(6):624-30. PubMed ID: 18456556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The cost of pulmonary tuberculosis treatment in the Congo].
    M'Boussa J
    Med Trop (Mars); 1991; 51(1):81-5. PubMed ID: 2072854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Current socioepidemiologic and clinico-pathogenetic aspects of pulmonary tuberculosis in the Republic of Moldova].
    Sain DO; Iavorskii KM; Emel'ianov OS; Bolotnikova VA; Brumar' AG
    Probl Tuberk; 1997; (1):17-9. PubMed ID: 9162912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [New criteria for discharge from ward in patients with pulmonary tuberculosis using mycobacteria growth indicator tube].
    Fujino M; Kishi F; Akiyama Y; Ogasawara H; Matsumoto H
    Kekkaku; 2007 Jan; 82(1):11-7. PubMed ID: 17310777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Criteria for evaluating the efficiency of chemotherapy in tuberculosis hospital].
    Parolina LE; Morozova TI; Doktorova NP
    Probl Tuberk Bolezn Legk; 2007; (6):13-7. PubMed ID: 17672056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delay in the diagnosis and treatment of pulmonary tuberculosis in patients attending a university teaching hospital.
    Liam CK; Tang BG
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):326-32. PubMed ID: 9432388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-term hospitalisation combined with supervised ambulatory treatment of tuberculosis.
    Riska H
    Scand J Respir Dis; 1972; 53(1):51-5. PubMed ID: 5052346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.